AbMole文献回馈活动一直在如火如荼地进行，我们也一直在对发表的文献进行收录整理，在产品品质和信息收集方面一直在做出不断地努力与改进。
2018年又是收获的一年，据统计，2018年SCI收录有AbMole产品文献数百篇，其中IF高分文献更是占据半数之多。我们整理了部分2018年AbMole高分文献数据，供大家了解和熟悉AbMole产品。
声明：此处文章整理，仅做方便科研人员了解AbMole产品只用。
1.【IF: 41.46】Cyclin D-CDK4 kinase destabilizes PD-L1 via Cul3SPOP to control cancer immune surveillance. Nature. 2018 Jan 4;553(7686):91-95.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29160310
2.【IF: 22.84】Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses. Cancer Cell. 2018 Sep 10;34(3):411-426.e19.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30146332
3.【IF: 21.95】Growth of Epithelial Organoids in a Defined Hydrogel. Adv Mater. 2018 Oct;30(43):e1801621.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30203567
4.【IF: 16.80】Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Sci Transl Med. 2018 May 16;10(441).
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29769286
5.【IF: 14.174】Modelling Cryptosporidium infection in human small intestinal and lung organoids. Nat Microbiol. 2018 Jul;3(7):814-823.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29946163
6.【IF: 13.204】Dicer1 deficiency in the IPF fibroblastic focus promotes fibrosis by suppressing microRNA biogenesis. AM J Resp Crit Care. 2018 Aug 15;198(4):486-496.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29579397
7.【IF: 10.199】Increased synthesis of MCL-1 protein underlies initial survival of EGFR mutant lung cancer to EGFR inhibitors and provides a novel drug target. Clin Cancer Res.2018 Nov 15;24(22):5658-5672.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30087143
8.【IF: 10.199】Targeting bromodomain and extra-terminal (BET) family proteins in castration resistant prostate cancer (CRPC). Clin Cancer Res. 2018 Jul 1;24(13):3149-3162.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29555663
9.【IF: 10.143】Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids. Cancer Discov. 2018 Nov;8(11):1404-1421.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30213835
10.【IF: 10.032】Measuring mutation accumulation in single human adult stem cells by whole-genome sequencing of organoid cultures. Nat Protoc. 2018 Jan;13(1):59-78.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29215633
11.【IF: 10.032】A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression. Nat Protoc. 2018 Feb;13(2):235-247.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29300390
12.【IF: 9.775】Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma. Blood. 2018 May 24;131(21):2345-2356.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29567799
13.【IF: 9.661】Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2594-E2603.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29476008
14.【IF: 9.571】Chloroplast Biogenesis Controlled by DELLATOC159 Interaction in Early Plant Development. Curr Biol. 2018 Aug 20;28(16):2616-2623.e5.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30078560
15.【IF: 7.837】Targeting bromodomain and extra-terminal (BET) family proteins in castration resistant prostate cancer (CRPC). Clin Cancer Res. 2018 Jul 1;24(13):3149-3162.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29555663
16.【IF: 7.644】A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice. OncoImmunology. 2018 Jan 16;7(5):e1421890.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29721370
17.【IF: 7.519】HIPK2 and extrachromosomal histone H2B are separately recruited by Aurora-B for cytokinesis. Oncogene. 2018 Jun;37(26):3562-3574.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29563611
18.【IF: 7.127】Loss of Blood-Brain Barrier Integrity in a KClInduced Model of Episodic Headache Enhances CNS Drug Delivery. eNeuro. 2018 Jul 16;5(4).
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30073201
19.【IF: 6.273】Tumor Necrosis Factor-α Is Required for Mast Cell-Mediated Host Immunity Against Cutaneous Staphylococcus aureus Infection. J Infect Dis. 2018 Jun 5;218(1):64-74.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29741644
20.【IF: 6.217】The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model. J Exp Clin Cancer Res. 2018 Nov;176:10-19.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29928901
21.【IF: 5.988】HIPK2-mediated transcriptional control of NMDA receptor subunit expression regulates neuronal survival and cell death. J Neurosci. 2018 Apr 18;38(16):4006-4019.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29581378
22.【IF: 5.965】Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer. Cell Death and Disease. 2018 Jan 26;9(2):137.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29374168
23.【IF: 5.965】Autophagy mediates glucose starvationinduced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival. Cell Death and Disease. 2018 Feb 12;9(2):213.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29434213
24.【IF: 5.965】Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer. Cell Death and Disease. 2017 Mar 15;65(10):2089-2099.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/28230361
25.【IF: 5.540】CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory. PLoS Genet. 2018 Jan 25;14(1):e1007165.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29370161
26.【IF: 5.498】Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells. FASEB J. 2018 May 29:fj201800011R.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/29812969
27.【IF: 5.423】Resveratrol protects photoreceptors by blocking caspase- and PARP-dependent cell death pathways. Free Radic Biol Med. 2018 Dec;129:569-581.
PMID: https://www.ncbi.nlm.nih.gov/pubmed/30342188
若您在AbMole购买产品并发表文献，但未被我公司收集，也请致电我司，我们将予以文献奖励，欢迎您积极参与到文献回馈活动中。